AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC

Regulatory Filings Jun 4, 2021

5066_rns_2021-06-04_4527dce8-bacd-4540-b436-4f355f0685e4.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 7967A

Oxford Cannabinoid Tech.Holdings

04 June 2021

RNS Reach

4 June 2021

Oxford Cannabinoid Technologies Holdings plc

Company presentation webinar to retail investors

Oxford Cannabinoid Technologies Holdings plc (LSE: OCTP), a UK based pharmaceutical company focussed on developing cannabinoid-based prescription medicines approved by regulatory agencies, is pleased to announce that its CEO, Dr. John Lucas, and Executive Chairman, Neil Mahapatra, will conduct two live presentations to retail investors following its recent admission to trading on the Main Market of the London Stock Exchange.

The presentations will provide an opportunity for potential investors to learn about the Company and its outlook for the year ahead.

The live webinars, hosted by AJ Bell/Shares and Yellowstone Advisers, will take place on Tuesday 8th June 2021 at 19.45 and Thursday 10 June 2021 at 13.00, respectively.

The online presentations are open to all existing and potential investors and registration is free. Questions can be submitted during the presentation and will be addressed at the end.  

To register, please go to:

-     AJ Bell/Shares - https://www.sharesmagazine.co.uk/events/event/shares-investor-evening--webinar-080621 

-     Yellowstone - https://www.yellowstoneadvisory.com/event-details/oxford-cannabinoid-technologies-plc-webinar 

For more information please contact:

Oxford Cannabinoid Technologies Holdings plc - Dr John Lucas (CEO)

079 5687 3125 / [email protected] 

PR Advisers: Acuitas Communications - James Gittings/Simon Nayyar

020 3848 2810 / [email protected] 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRADZGGVVFDGMZM

Talk to a Data Expert

Have a question? We'll get back to you promptly.